CBT-WPD: Group Therapy Program for Women With Physical Disabilities

Sponsor
Oregon Health and Science University (Other)
Overall Status
Completed
CT.gov ID
NCT00618566
Collaborator
U.S. Department of Education (U.S. Fed)
82
1
1
59
1.4

Study Details

Study Description

Brief Summary

More women with disabilities (30%) report "feelings such as sadness, unhappiness, or depression that prevent them from being active" compared to women without disabilities (8%). The contexts of the lives of WPD, which often include high rates of poverty, architectural and attitudinal barriers, and higher vulnerability to violence and abuse, contribute to this mental health disparity. To help address this disparity, the overall goals of this pilot study are to: 1)1. Develop a cognitive behavioral group therapy intervention to address the specific needs of WPD who experience depressive symptoms; and 2. Pilot-test the intervention to preliminarily evaluate its efficacy using a mixed-methods approach. The proposed and revised study outcomes were derived from our previous work with WPD as well as from feedback obtained from community meetings conducted since our last submission of this proposal. A pilot of the modified intervention with a total of 90 participants will be conducted using a using a wait list control design. The decision to use a wait list control design was made jointly with our community partners to ensure that all WPD participating in the study have access to the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: WPD and Depression Treatment Group
N/A

Detailed Description

The project will use a longitudinal mixed method research design. Phase I will utilize focus groups conducted with WPD to support development of the group therapy program. Phase II will evaluate the efficacy of the intervention using a randomized design. Measures to protect human subjects include development of detailed safety and referral protocols including 24 hour access to emergency mental health assessment and intervention as needed.

Study Design

Study Type:
Interventional
Actual Enrollment :
82 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Peer Implemented Cognitive Behavioral Group Therapy Intervention for Use With Women With Physical Disabilities With Secondary Depression
Study Start Date :
Oct 1, 2007
Actual Primary Completion Date :
Sep 1, 2012
Actual Study Completion Date :
Sep 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Oregon

Behavioral: WPD and Depression Treatment Group
Intervention selected will depend on Phase I data analysis.

Outcome Measures

Primary Outcome Measures

  1. The following hypothesis is specific to the primary outcome: Hypotheses: 1. WPD receiving the intervention will demonstrate a greater improvement in depressive symptom scores compared to participants in the wait-list control groups. [3 years]

Secondary Outcome Measures

  1. Secondary Outcomes: Hypothesis 2: the intervention group will demonstrate a greater improvement in coping and problem-solving skills, health behavior, body image and sexual self-esteem and loneliness compared to wait-listed controls. [3 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women with physical disabilities age 18 and older who require some form of accommodation and experience significant depressive symptoms as defined by a cut off score of 16 or greater on the CES-D.
Exclusion Criteria:
  • Women currently receiving other psychotherapy treatment

  • Women who are psychotic or have significant cognitive impairment

  • Women who are actively suicidal with intent and plan

  • Women who have discontinued or initiated antidepressant medications within an 4 week time period.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oregon Health & Science University Portland Oregon United States 97239

Sponsors and Collaborators

  • Oregon Health and Science University
  • U.S. Department of Education

Investigators

  • Principal Investigator: Dena Hassouneh, PhD, Oregon Health and Science University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dena Hassouneh, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT00618566
Other Study ID Numbers:
  • NIDRR
  • H133G060135
First Posted:
Feb 20, 2008
Last Update Posted:
Oct 17, 2012
Last Verified:
Oct 1, 2012
Keywords provided by Dena Hassouneh, Associate Professor, Oregon Health and Science University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 17, 2012